Activation of the vascular niche supports leukemic progression and resistance to chemotherapy

Experimental Hematology

Volumn 42, Issue 11, 2014, Pages 976-986.e3

  Poulos, Michael G ^a   Gars, Eric J ^a   Gutkin, Michael C ^a   Kloss, Christopher C ^a   Ginsberg, Michael ^b   Scandura, Joseph M ^a   Rafii, Shahin ^a   Butler, Jason M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Angiocrine Bioscience   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VEGFR2 PROTEIN, MOUSE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PARAMETERS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CELL ACTIVATION; CELL ADHESION; CELL CLONE; CELL PROLIFERATION; ENDOTHELIUM CELL; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; VASCULAR NICHE ACTIVATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BONE MARROW; C57BL MOUSE; CANCER STEM CELL; COCULTURE; DISEASE MODEL; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LEUKEMIA, MYELOID, ACUTE; METABOLISM; PATHOLOGY; TRANSFORMED CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW; CELL ADHESION; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELLULAR MICROENVIRONMENT; CLONE CELLS; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84912060548     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2014.08.003     Document Type: Article

References (37)

1. Goldstone A.H., Burnett A.K., Wheatley K., et al. Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: The results of the United Kingdom Medical Research Council AML11 trial. Blood 2001, 98:1302-1311.
2. Lowenberg B., Downing J.R., Burnett A. Acute myeloid leukemia. NEngl J Med 1999, 341:1051-1062.
3. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
4. Park C.Y., Tseng D., Weissman I.L. Cancer stem cell-directed therapies: Recent data from the laboratory and clinic. Mol Ther 2009, 17:219-230.
5. Sengupta A., Arnett J., Dunn S., Williams D.A., Cancelas J.A. Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors invivo. Blood 2010, 116:81-84.
6. Wang Y., Krivtsov A.V., Sinha A.U., et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010, 327:1650-1653.
7. Zhao C., Chen A., Jamieson C.H., et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009, 458:776-779.
8. Hooper A.T., Butler J.M., Nolan D.J., et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009, 4:263-274.
9. Lo Celso C., Fleming H.E., Wu J.W., et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 2009, 457:92-96.
10. Xie Y., Yin T., Wiegraebe W., et al. Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 2009, 457:97-101.
11. Ding L., Saunders T.L., Enikolopov G., Morrison S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012, 481:457-462.
12. Himburg H.A., Harris J.R., Ito T., et al. Pleiotrophin regulates the retention and self-renewal of hematopoietic stem cells in the bone marrow vascular niche. Cell Rep 2012, 2:964-975.
13. Himburg H.A., Muramoto G.G., Daher P., et al. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat Med 2010, 16:475-482.
14. Kobayashi H., Butler J.M., O'Donnell R., et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 2010, 12:1046-1056.
15. Raaijmakers M.H., Mukherjee S., Guo S., et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010, 464:852-857.
16. Butler J.M., Gars E.J., James D.J., Nolan D.J., Scandura J.M., Rafii S. Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells. Blood 2012, 120:1344-1347.
17. Butler J.M., Nolan D.J., Vertes E.L., et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 2010, 6:251-264.
18. Mendez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
19. Ding L., Morrison S.J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013, 495:231-235.
20. Kunisaki Y., Bruns I., Scheiermann C., et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 2013, 502:637-643.
21. Poulos M.G., Guo P., Kofler N.M., et al. Endothelial jagged-1 is necessary for homeostatic and regenerative hematopoiesis. Cell Rep 2013, 4:1022-1034.
22. Matsunaga T., Takemoto N., Sato T., et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 2003, 9:1158-1165.
23. Ishikawa F., Yoshida S., Saito Y., et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 2007, 25:1315-1321.
24. Iwamoto S., Mihara K., Downing J.R., Pui C.H., Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 2007, 117:1049-1057.
25. Cogle C.R., Goldman D.C., Madlambayan G.J., et al. Functional integration of acute myeloid leukemia into the vascular niche. Leukemia 2014, E-pub ahead of print.
26. Pezeshkian B., Donnelly C., Tamburo K., Geddes T., Madlambayan G.J. Leukemia mediated endothelial cell activation modulates leukemia cell susceptibility to chemotherapy through a positive feedback loop mechanism. PLoS One 2013, 8:e60823.
27. Kunisaki Y., Frenette P.S. The secrets of the bone marrow niche: Enigmatic niche brings challenge for HSC expansion. Nat Med 2012, 18:864-865.
28. Butler J.M., Kobayashi H., Rafii S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 2010, 10:138-146.
29. Seandel M., Butler J.M., Kobayashi H., et al. Generation of a functional and durable vascular niche by the adenoviral E4ORF1 gene. Proc Natl Acad Sci U S A 2008, 105:19288-19293.
30. Dias S., Hattori K., Zhu Z., et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 2000, 106:511-521.
31. Aguayo A., Kantarjian H.M., Estey E.H., et al. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Cancer 2002, 95:1923-1930.
32. Kuzu I., Beksac M., Arat M., Celebi H., Elhan A.H., Erekul S. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): Therapy induced changes and effects on survival. Leuk Lymphoma 2004, 45:1185-1190.
33. Krivtsov A.V., Twomey D., Feng Z., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006, 442:818-822.
34. Hussong J.W., Rodgers G.M., Shami P.J. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000, 95:309-313.
35. Dias S., Hattori K., Heissig B., et al. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci U S A 2001, 98:10857-10862.
36. Trujillo A., McGee C., Cogle C.R. Angiogenesis in acute myeloid leukemia and opportunities for novel therapies. J Oncol 2012, 2012:128608.
37. Madlambayan G.J., Meacham A.M., Hosaka K., et al. Leukemia regression by vascular disruption and antiangiogenic therapy. Blood 2010, 116:1539-1547.